![]() Boehringer Ingelheim Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing. | ![]() Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. | |
Founding Date | Founding Date 1958 | Founding Date 1876 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Ingelheim am Rhein, DE HQ Ouled Fayet, DZ Munro, AR Macquarie Park, AU Wien, AT Minsk, BY Bruxelles, BE see more | Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more |
Employees | Employees 1,2338% increase | Employees 47,0009% increase |
Financial | ||
Revenue (est.) | Revenue (est.) €12.7b (FY, 2023) | Revenue (est.) $65.2b (FY, 2025) |
Cost of goods | Cost of goods €4b (FY, 2023) | Cost of goods $11.1b (FY, 2025) |
Gross profit | Gross profit €8.7b (FY, 2023) | Gross profit $54.1b (FY, 2025) |
Net income | Net income €5.8b (FY, 2023) | Net income $20.6b (FY, 2025) |

Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.
View company